Uipath Inc Financials

PATH

Source SEC Filings (10-K/10-Q) Updated Oct 31, 2025 Currency USD FYE January

This page shows Uipath Inc (PATH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 69/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Uipath Inc has an operating margin of -11.4%, meaning the company retains $-11 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -12.6% the prior year.

Growth

Uipath Inc's revenue grew 9.3% year-over-year to $1.4B, a solid pace of expansion. This earns a growth score of 55/100.

Leverage

Uipath Inc carries a low D/E ratio of 0.56, meaning only $0.56 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 2.95, Uipath Inc holds $2.95 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 98/100.

Cash Flow

100

Uipath Inc converts 21.4% of revenue into free cash flow ($305.6M). This strong cash generation earns a score of 100/100.

Piotroski F-Score Neutral

4/9

Uipath Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-4.35x

For every $1 of reported earnings, Uipath Inc generates $-4.35 in operating cash flow ($320.6M OCF vs -$73.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Revenue

$1.4B

YoY+9.3%

5Y CAGR+33.6%

Uipath Inc generated $1.4B in revenue in fiscal year 2025. This represents an increase of 9.3% from the prior year.

EBITDA

-$145.3M

YoY-2.3%

Uipath Inc's EBITDA was -$145.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2.3% from the prior year.

Free Cash Flow

$305.6M

YoY+4.8%

Uipath Inc generated $305.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 4.8% from the prior year.

Net Income

-$73.7M

YoY+18.0%

Uipath Inc reported -$73.7M in net income in fiscal year 2025. This represents an increase of 18.0% from the prior year.

EPS (Diluted)

$-0.13

YoY+18.8%

Uipath Inc earned $-0.13 per diluted share (EPS) in fiscal year 2025. This represents an increase of 18.8% from the prior year.

Cash & Debt

$700.6M

YoY-38.9%

5Y CAGR+18.7%

Uipath Inc held $700.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Gross Margin

82.7%

YoY-2.3pp

5Y CAGR+0.4pp

Uipath Inc's gross margin was 82.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.3 percentage points from the prior year.

Operating Margin

-11.4%

YoY+1.2pp

5Y CAGR+142.5pp

Uipath Inc's operating margin was -11.4% in fiscal year 2025, reflecting core business profitability. This is up 1.2 percentage points from the prior year.

Net Margin

-5.1%

YoY+1.7pp

5Y CAGR+149.5pp

Uipath Inc's net profit margin was -5.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.7 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$380.7M

YoY+14.6%

5Y CAGR+23.8%

Uipath Inc invested $380.7M in research and development in fiscal year 2025. This represents an increase of 14.6% from the prior year.

Share Buybacks

$390.8M

YoY+280.8%

5Y CAGR+24.8%

Uipath Inc spent $390.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 280.8% from the prior year.

Capital Expenditures

$14.9M

YoY+103.3%

5Y CAGR-1.1%

Uipath Inc invested $14.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 103.3% from the prior year.

PATH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.4B+9.3%	$1.3B+23.6%	$1.1B+18.6%	$892.3M+46.8%	$607.6M+80.8%	$336.2M
Cost of Revenue	$246.9M+26.0%	$195.9M+8.8%	$180.1M+6.6%	$168.9M+156.4%	$65.9M+10.9%	$59.4M
Gross Profit	$1.2B+6.3%	$1.1B+26.6%	$878.5M+21.4%	$723.4M+33.5%	$541.8M+95.8%	$276.8M
R&D Expenses	$380.7M+14.6%	$332.1M+16.2%	$285.8M+3.3%	$276.7M+151.7%	$109.9M-16.1%	$131.1M
SG&A Expenses	$226.1M-2.4%	$231.6M-3.3%	$239.5M-4.2%	$250.0M+54.3%	$162.0M-9.8%	$179.6M
Operating Income	-$162.6M+1.3%	-$164.7M+52.7%	-$348.3M+30.5%	-$500.9M-354.1%	-$110.3M+78.7%	-$517.3M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$4.4M-131.3%	$14.1M+30.4%	$10.8M-26.6%	$14.7M+749.1%	-$2.3M-181.1%	$2.8M
Net Income	-$73.7M+18.0%	-$89.9M+72.6%	-$328.4M+37.5%	-$525.6M-468.9%	-$92.4M+82.2%	-$519.9M
EPS (Diluted)	$-0.13+18.8%	$-0.16+73.3%	$-0.60+48.3%	$-1.16-110.9%	$-0.55+83.9%	$-3.41

Metric	Q3'26	Q2'26	Q1'26	Q4'24	Q3'25	Q2'25	Q1'25	Q4'23
Revenue	$411.1M+13.7%	$361.7M+1.4%	$356.6M-12.0%	$405.3M+24.3%	$325.9M+13.4%	$287.3M-0.8%	$289.6M-6.1%	$308.5M
Cost of Revenue	$68.8M+6.9%	$64.4M+0.8%	$63.9M+19.7%	$53.4M+6.9%	$49.9M+1.9%	$49.0M+12.2%	$43.7M-8.4%	$47.7M
Gross Profit	$342.3M+15.1%	$297.3M+1.6%	$292.8M-16.8%	$351.9M+27.5%	$276.0M+15.8%	$238.3M-3.1%	$245.9M-5.7%	$260.9M
R&D Expenses	$96.9M-1.5%	$98.3M+3.7%	$94.8M+10.7%	$85.6M+1.3%	$84.5M-2.4%	$86.6M+15.0%	$75.3M-8.0%	$81.9M
SG&A Expenses	$53.2M+0.5%	$52.9M-3.3%	$54.7M-8.0%	$59.5M+6.1%	$56.0M-6.0%	$59.6M+5.3%	$56.6M+12.3%	$50.4M
Operating Income	$13.1M+164.8%	-$20.2M-23.0%	-$16.4M-208.7%	$15.1M+127.0%	-$55.8M+28.1%	-$77.6M-67.2%	-$46.4M-2.8%	-$45.1M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$174.2M-10097.0%	$1.7M-38.3%	$2.8M+5.5%	$2.7M-31.7%	$3.9M+2.5%	$3.8M+5.5%	$3.6M+397.5%	$730K
Net Income	$198.8M+12453.0%	$1.6M+107.0%	-$22.6M-166.5%	$33.9M+207.5%	-$31.5M+47.8%	-$60.4M-89.2%	-$31.9M-15.2%	-$27.7M
EPS (Diluted)	$0.37	$0.00+100.0%	$-0.04-157.1%	$0.07+216.7%	$-0.06+45.5%	$-0.11-83.3%	$-0.06-20.0%	$-0.05

PATH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$2.6B-7.0%	$2.8B+7.7%	$2.6B+9.0%	$2.4B+5.1%	$2.3B+166.2%	$866.5M
Current Assets	$2.1B-14.6%	$2.5B+9.4%	$2.3B+5.2%	$2.1B+1.2%	$2.1B+188.6%	$734.4M
Cash & Equivalents	$700.6M-38.9%	$1.1B-12.6%	$1.3B-21.9%	$1.7B-6.5%	$1.8B+505.1%	$296.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$266.6M-1.5%	$270.6M+16.0%	$233.3M+38.0%	$169.1M+23.8%	$136.5M-20.8%	$172.3M
Goodwill	$121.4M+37.3%	$88.4M-0.9%	$89.2M+71.1%	$52.1M+71.1%	$30.5M+8.6%	$28.1M
Total Liabilities	$946.0M+15.6%	$818.0M+19.0%	$687.1M+26.2%	$544.5M+33.8%	$407.0M-76.1%	$1.7B
Current Liabilities	$715.9M+19.8%	$597.5M+18.7%	$503.4M+14.9%	$438.2M+33.4%	$328.6M-10.0%	$365.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.7B-16.2%	$2.0B+3.7%	$2.0B+4.0%	$1.9B-1.0%	$1.9B+327.4%	-$835.3M
Retained Earnings	-$2.0B-3.5%	-$1.9B-4.7%	-$1.9B-14.7%	-$1.6B-33.8%	-$1.2B-24.7%	-$970.4M

Metric	Q3'26	Q2'26	Q1'26	Q4'24	Q3'25	Q2'25	Q1'25	Q4'23
Total Assets	$2.9B+11.7%	$2.6B-2.0%	$2.6B-10.5%	$3.0B+6.0%	$2.8B+4.4%	$2.7B+1.0%	$2.6B-3.4%	$2.7B
Current Assets	$2.1B+3.1%	$2.0B-3.7%	$2.1B-18.2%	$2.6B+6.2%	$2.4B+5.5%	$2.3B+2.1%	$2.3B-3.7%	$2.3B
Cash & Equivalents	$743.7M+18.3%	$628.6M-10.3%	$700.6M-34.0%	$1.1B+5.8%	$1.0B-8.3%	$1.1B-16.6%	$1.3B-6.5%	$1.4B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$366.8M+35.9%	$269.8M+1.2%	$266.6M-38.9%	$436.3M+16.9%	$373.1M+64.8%	$226.3M-3.0%	$233.3M-37.7%	$374.2M
Goodwill	$120.6M-0.1%	$120.8M-0.5%	$121.4M+36.3%	$89.0M+2.0%	$87.3M-3.1%	$90.1M+0.9%	$89.2M+1.4%	$88.0M
Total Liabilities	$971.4M+4.8%	$926.6M-2.0%	$946.0M+0.8%	$938.6M+13.7%	$825.8M+20.2%	$686.8M-0.1%	$687.1M-15.7%	$815.0M
Current Liabilities	$788.7M+6.8%	$738.4M+3.2%	$715.9M+0.6%	$711.7M+13.4%	$627.7M+21.1%	$518.1M+2.9%	$503.4M-19.6%	$626.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.9B+15.5%	$1.7B-1.9%	$1.7B-15.8%	$2.0B+2.8%	$2.0B-1.1%	$2.0B+1.4%	$2.0B+1.8%	$1.9B
Retained Earnings	-$1.8B+9.9%	-$2.0B+0.1%	-$2.0B-5.0%	-$1.9B+1.7%	-$1.9B-1.6%	-$1.9B-3.3%	-$1.9B-1.7%	-$1.8B

PATH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$320.6M+7.2%	$299.1M+3096.5%	-$10.0M+81.8%	-$55.0M-288.4%	$29.2M+108.1%	-$359.4M
Capital Expenditures	$14.9M+103.3%	$7.3M-69.2%	$23.8M+168.2%	$8.9M+354.6%	$2.0M-87.6%	$15.7M
Free Cash Flow	$305.6M+4.8%	$291.7M+963.2%	-$33.8M+47.1%	-$63.8M-334.5%	$27.2M+107.3%	-$375.2M
Investing Cash Flow	-$45.5M+89.6%	-$439.6M-52.0%	-$289.1M-715.8%	-$35.4M+71.9%	-$126.0M-218.9%	-$39.5M
Financing Cash Flow	-$450.5M-128.8%	-$196.9M-224.5%	-$60.7M-104.1%	$1.5B+486.9%	$250.4M-45.3%	$457.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$390.8M+280.8%	$102.6M	$0	$0	$0-100.0%	$128.8M

Metric	Q3'26	Q2'26	Q1'26	Q4'24	Q3'25	Q2'25	Q1'25	Q4'23
Operating Cash Flow	$28.3M-32.0%	$41.6M-65.1%	$119.0M-18.3%	$145.6M+247.9%	$41.9M-5.5%	$44.3M-34.2%	$67.3M-28.3%	$94.0M
Capital Expenditures	$3.2M	$0-100.0%	$12.8M+239.1%	$3.8M+454.8%	$682K-32.2%	$1.0M-46.2%	$1.9M-15.0%	$2.2M
Free Cash Flow	$25.1M-39.6%	$41.6M-60.8%	$106.2M-25.1%	$141.8M+244.5%	$41.2M-4.9%	$43.3M-33.9%	$65.5M-28.6%	$91.8M
Investing Cash Flow	$100.8M+15483.8%	-$655K+99.2%	-$79.9M-825.1%	-$8.6M+85.7%	-$60.3M+74.4%	-$235.1M-73.5%	-$135.6M-7.2%	-$126.5M
Financing Cash Flow	-$11.2M+90.0%	-$111.6M+52.6%	-$235.2M-187.1%	-$81.9M-18.5%	-$69.2M-174.4%	-$25.2M-22.1%	-$20.6M-22.3%	-$16.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$101.6M-55.4%	$227.5M+355.4%	$50.0M-5.1%	$52.6M	$0	$0	$0

PATH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	82.7%-2.3pp	85.0%+2.0pp	83.0%+1.9pp	81.1%-8.1pp	89.2%+6.8pp	82.3%
Operating Margin	-11.4%+1.2pp	-12.6%+20.3pp	-32.9%+23.2pp	-56.1%-38.0pp	-18.2%+135.7pp	-153.9%
Net Margin	-5.1%+1.7pp	-6.9%+24.1pp	-31.0%+27.9pp	-58.9%-43.7pp	-15.2%+139.5pp	-154.7%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-2.8%+0.4pp	-3.2%+9.3pp	-12.4%+9.3pp	-21.7%-17.7pp	-4.0%+56.0pp	-60.0%
Current Ratio	2.95-1.2	4.13-0.4	4.48-0.4	4.89-1.6	6.45+4.4	2.01
Debt-to-Equity	0.56+0.2	0.40+0.1	0.35+0.1	0.29+0.1	0.21+2.3	-2.04
FCF Margin	21.4%-0.9pp	22.3%+25.5pp	-3.2%+4.0pp	-7.2%-11.6pp	4.5%+116.1pp	-111.6%

Metric	Q3'26	Q2'26	Q1'26	Q4'24	Q3'25	Q2'25	Q1'25	Q4'23
Gross Margin	83.3%+1.1pp	82.2%+0.1pp	82.1%-4.7pp	86.8%+2.2pp	84.7%+1.7pp	83.0%-2.0pp	84.9%+0.4pp	84.5%
Operating Margin	3.2%+8.8pp	-5.6%-1.0pp	-4.6%-8.3pp	3.7%+20.9pp	-17.1%+9.9pp	-27.0%-11.0pp	-16.0%-1.4pp	-14.6%
Net Margin	48.4%+47.9pp	0.4%+6.8pp	-6.3%-14.7pp	8.4%+18.1pp	-9.7%+11.3pp	-21.0%-10.0pp	-11.0%-2.1pp	-9.0%
Return on Equity	10.3%+10.2pp	0.1%	N/A	1.7%	N/A	N/A	N/A	N/A
Return on Assets	6.9%+6.8pp	0.1%+0.9pp	-0.9%-2.0pp	1.1%+2.3pp	-1.1%+1.1pp	-2.3%-1.0pp	-1.2%-0.2pp	-1.0%
Current Ratio	2.65-0.1	2.75-0.2	2.95-0.7	3.63-0.2	3.87-0.6	4.45-0.0	4.48+0.7	3.74
Debt-to-Equity	0.50-0.1	0.560.0	0.56+0.1	0.47+0.0	0.42+0.1	0.350.0	0.35-0.1	0.42
FCF Margin	6.1%-5.4pp	11.5%-18.3pp	29.8%-5.2pp	35.0%+22.4pp	12.6%-2.4pp	15.1%-7.5pp	22.6%-7.1pp	29.7%

Similar Companies

$3.0B

$4.6B

$5.3B

$7.6B

$11.0B

Frequently Asked Questions

What is Uipath Inc's annual revenue?

Uipath Inc (PATH) reported $1.4B in total revenue for fiscal year 2025. This represents a 9.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Uipath Inc's revenue growing?

Uipath Inc (PATH) revenue grew by 9.3% year-over-year, from $1.3B to $1.4B in fiscal year 2025.

Is Uipath Inc profitable?

No, Uipath Inc (PATH) reported a net income of -$73.7M in fiscal year 2025, with a net profit margin of -5.1%.

What is Uipath Inc's earnings per share (EPS)?

Uipath Inc (PATH) reported diluted earnings per share of $-0.13 for fiscal year 2025. This represents a 18.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Uipath Inc's EBITDA?

Uipath Inc (PATH) had EBITDA of -$145.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Uipath Inc's gross margin?

Uipath Inc (PATH) had a gross margin of 82.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Uipath Inc's operating margin?

Uipath Inc (PATH) had an operating margin of -11.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Uipath Inc's net profit margin?

Uipath Inc (PATH) had a net profit margin of -5.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Uipath Inc's free cash flow?

Uipath Inc (PATH) generated $305.6M in free cash flow during fiscal year 2025. This represents a 4.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Uipath Inc's operating cash flow?

Uipath Inc (PATH) generated $320.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Uipath Inc's total assets?

Uipath Inc (PATH) had $2.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Uipath Inc's capital expenditures?

Uipath Inc (PATH) invested $14.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Uipath Inc spend on research and development?

Uipath Inc (PATH) invested $380.7M in research and development during fiscal year 2025.

Does Uipath Inc buy back shares?

Yes, Uipath Inc (PATH) spent $390.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Uipath Inc's current ratio?

Uipath Inc (PATH) had a current ratio of 2.95 as of fiscal year 2025, which is generally considered healthy.

What is Uipath Inc's debt-to-equity ratio?

Uipath Inc (PATH) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Uipath Inc's return on assets (ROA)?

Uipath Inc (PATH) had a return on assets of -2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Uipath Inc's Piotroski F-Score?

Uipath Inc (PATH) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Uipath Inc's earnings high quality?

Uipath Inc (PATH) has an earnings quality ratio of -4.35x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Uipath Inc?

Uipath Inc (PATH) scores 69 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.